Vectura Group (VEC LN)

Vectura Group plc is a British pharmaceuticals company that specializes in the development of inhaled medicines and inhaler devices for treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It operates as a contract development and manufacturing organization (CDMO), offering formulation, device design, and development capabilities to help other companies bring inhaled therapies to market. The company was founded in 1997 and is headquartered in Chippenham, England, UK.